Global  

Pfizer, BioNTech get vaccine 'fast track' from FDA

Video Credit: Reuters - Politics - Duration: 01:02s - Published
Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer Inc and partner BioNTech SE said on Monday two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration, speeding up the regulatory review process.

Jillian Kitchener has more.

Pfizer and its German partner BioNTech on Monday announced two of their experimental coronavirus vaccines received 'fast track' designation from the U.S. Food and Drug Administration.

...meaning the FDA may decide on an approval within six months.

If a vaccine candidate gets the green light, the companies said they expect to make up to 100 million doses by the end of this year.

The companies said the recent testing of an experimental vaccine on 24 healthy volunteers showed that after 28 days they had developed higher levels of COVID-19 antibodies than typically seen in infected people.

Upon regulatory approval, the companies expect to start a large trial with up to 30,000 participants… possibly later this month - paving the way toward a potential release of a vaccine.

The U.S. and other countries have poured billions into developing a safe and effective vaccine for COVID-19.

As of now - none are approved.




You Might Like


💡 One News Page Knowledge: Other News Mentions

Pfizer Pfizer American multinational pharmaceutical corporation

Coronavirus updates: Chicago curfew begins Friday night; Pfizer adds teens to vaccine trial; NBA Draft to go virtual; 223K US deaths

Chicago imposes 10 p.m. curfew for two weeks. Wyoming reports 10,000th case. Southwest Airlines to start filling middle seats. Latest COVID news.

USATODAY.com

Pfizer has expanded its COVID-19 vaccine trial to include teens. Some say it's risky. Others argue it's necessary.

After months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16.
 

USATODAY.com

Alzheimer's disease: IBM study cites language use as an early sign of disease

A study performed by IBM and funded by Pfizer found a computerized model analyzing language patterns accurately Alzheimer's disease later in life.

USATODAY.com

Food and Drug Administration Food and Drug Administration Agency of the United States Department of Health and Human Services

This week on "Face the Nation," October 25, 2020

National Security Adviser Robert O'Brien, and FDA Commissioner Scott Gottlieb appear on Sunday's "Face the Nation"
CBS News

FDA approves remdesivir as COVID-19 treatment

The Food and Drug Administration approved the antiviral drug remdesivir to treat adults who are hospitalized with COVID-19, although it has not been proven to..
CBS News
Gilead's remdesivir gets U.S. FDA approval [Video]

Gilead's remdesivir gets U.S. FDA approval

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Gavino Garay reports.

Credit: Reuters Studio    Duration: 01:29Published

Covid 19 coronavirus: FDA approves first drug: antiviral remdesivir

US regulators on Thursday approved the first drug to treat Covid-19: remdesivir, an antiviral medicine given to hospitalised patients through an IV.The drug,..
New Zealand Herald

FDA approves remdesivir as first treatment for coronavirus

The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes..
CBS News

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

US election 2020: Pence stays campaigning despite aide's Covid diagnosis

The US vice-president has tested negative himself and says he will not self-isolate.
BBC News

Drive-thru haunted houses make for a spooky, COVID-safe Halloween

Luke Burbank takes a look at how some places are setting up drive-thru haunted houses for a spooky — and healthy — Halloween. One of these places is a car..
CBS News

'He's not just campaigning, he's working': Pence will still campaign, despite aide's COVID-19 case

CDC guidelines call for people to quarantine after exposure, but Mark Meadows cited exceptions for "essential personnel" like the vice president.

USATODAY.com

Reserve Bank of India governor Shakti Kanta Das tests positive for COVID-19

Das tweeted that he has tested positive for coronavirus and that he is asymptomatic.
DNA
'India's response to China...': RSS chief Mohan Bhagwat on Ladakh tension [Video]

'India's response to China...': RSS chief Mohan Bhagwat on Ladakh tension

Mohan Bhagwat, Sarsanghchalak of the Rashtriya Swayamsevak Sangh (RSS), spoke on the ongoing tension with China along the Line of Actual Control (LAC) in Ladakh. He said that India's response had subdued the neighbouring nation and dealt it a blow. He made the comments during his annual Dussehra address. He also performed 'shastra puja' or worship of weapons reportedly at the Maharshi Vyas auditorium in Maharashtra's Nagpur. Only 50 participants were allowed inside the venue due to the Covid-19 pandemic, as per reports. Watch the full video for more.

Credit: HT Digital Content    Duration: 03:39Published

Related news from verified sources

News24.com | WATCH | Pfizer, BioNTech get vaccine 'fast track' from FDA

Pfizer and partner BioNTech said two of their experimental coronavirus vaccines received 'fast track'...
News24 - Published Also reported by •Proactive Investors


UK government orders 30mln doses of Pfizer and BioNTech COVID-19 vaccine

The UK government has ordered 30mln does of Pfizer's (NYSE:PFE) and BioNTech’s (NASDAQ:BNTX) new...
Proactive Investors - Published

Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX)

Pfizer and BioNTech shares rise after FDA grants 2 coronavirus vaccines 'fast track' status (PFE, BNTX) ** · *Two experimental coronavirus vaccines developed by Pfizer and BioNTech received Fast Track...
Business Insider - Published


Tweets about this


Related videos from verified sources

US to Pay Pfizer and BioNTech $2B for 100 Million Doses of COVID-19 Vaccine [Video]

US to Pay Pfizer and BioNTech $2B for 100 Million Doses of COVID-19 Vaccine

The deal was announced on Wednesday.

Credit: Cover Video STUDIO     Duration: 01:11Published
U.S. pays Pfizer, BioNTech $2 bln for vaccines [Video]

U.S. pays Pfizer, BioNTech $2 bln for vaccines

The U.S. government will pay $1.95 billion to buy 100 million doses of Pfizer's and German biotech firm BioNTech's COVID-19 vaccine candidate if they are able to successfully develop one, the companies..

Credit: Reuters Studio     Duration: 01:15Published
UK Orders 90 Million COVID-19 Vaccine Doses from Pfizer and Valneva [Video]

UK Orders 90 Million COVID-19 Vaccine Doses from Pfizer and Valneva

The United Kingdom will receive 30 million doses of Pfizer and BioNTech's vaccine candidate, making it the partnership's first agreement with any government.

Credit: Cover Video STUDIO     Duration: 01:05Published